Physician profile
Monzer M Saad
NPI 1609009778
$3,075.47
in general payments reported to CMS, 2019-2025
13 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $103 · 2021: $209 · 2022: $378 · 2023: $820 · 2024: $706 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,084.17 | 2021-2025 | Teflaro, Dalvance, Avycaz |
| Janssen Pharmaceuticals, INC | $525.97 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $305.22 | 2019-2024 | |
| Pfizer INC. | $243.24 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $242.15 | 2019-2023 | Eliquis, Camzyos |
| Astellas Pharma US INC | $212.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $180.63 | 2019-2023 | Farxiga, Brilinta |
| Allergan, INC. | $104.96 | 2019-2020 | |
| Gilead Sciences, INC. | $67.05 | 2021 | |
| Boston Scientific Corporation | $41.46 | 2023-2024 | Watchman Access System, Wavewriter Alpha Prime 16 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.68 | 2020 | |
| Philips North America LLC | $19.20 | 2023 | |
| Teleflex LLC | $17.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monzer Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.